» Articles » PMID: 22258261

Identification of a Specific Region in the E1 Fusion Protein Involved in Zinc Inhibition of Semliki Forest Virus Fusion

Overview
Journal J Virol
Date 2012 Jan 20
PMID 22258261
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The enveloped alphaviruses infect cells via a low-pH-triggered membrane fusion reaction mediated by the viral transmembrane protein E1. During fusion, E1 inserts into the target membrane and refolds to a hairpin-like postfusion conformation in which domain III (DIII) and the juxtamembrane stem pack against a central core trimer. Although zinc has previously been shown to cause a striking block in alphavirus fusion with liposome target membranes, the mechanism of zinc's effect on the E1 fusion protein is not understood. Here we developed a cell culture system to study zinc inhibition of fusion and infection of the alphavirus Semliki Forest virus (SFV). Inclusion of 2 mM ZnCl(2) in the pH 5.75 fusion buffer caused a decrease of ∼5 logs in SFV fusion at the plasma membrane. Fusion was also inhibited by nickel, a chemically related transition metal. Selection for SFV zinc resistance identified a key histidine residue, H333 on E1 DIII, while other conserved E1 histidine residues were not involved. An H333N mutation conferred resistance to both zinc and nickel, with properties in keeping with the known pH-dependent chelation of these metals by histidine. Biochemical studies demonstrated that zinc strongly inhibits formation of the postfusion E1 trimer in wild-type SFV but not in an H333 mutant. Together our results suggest that zinc acts by blocking the fold-back of DIII via its interaction with H333.

Citing Articles

Explorations on the antiviral potential of zinc and magnesium salts against chikungunya virus: implications for therapeutics.

Davuluri K, Shukla S, Kakade M, Cherian S, Alagarasu K, Parashar D Front Cell Infect Microbiol. 2024; 14:1335189.

PMID: 38895735 PMC: 11183322. DOI: 10.3389/fcimb.2024.1335189.


Immunomodulatory Effects of Vitamin D and Zinc on Viral Infection.

Rizwan M, Cheng K, Gang Y, Hou Y, Wang C Biol Trace Elem Res. 2024; 203(1):1-17.

PMID: 38451442 DOI: 10.1007/s12011-024-04139-y.


Antiviral activity of zinc against hepatitis viruses: current status and future prospects.

Kumar S, Ansari S, Narayanan S, Ranjith-Kumar C, Surjit M Front Microbiol. 2023; 14:1218654.

PMID: 37908540 PMC: 10613677. DOI: 10.3389/fmicb.2023.1218654.


Upper Airways Spray for Viral Infections Prevention.

Palmieri B, Vadala M J Immunol Res. 2022; 2022:2502199.

PMID: 36249418 PMC: 9553441. DOI: 10.1155/2022/2502199.


Molecular mechanisms and therapeutic effects of different vitamins and minerals in COVID-19 patients.

Karami Fath M, Naderi M, Hamzavi H, Ganji M, Shabani S, Noorabad Ghahroodi F J Trace Elem Med Biol. 2022; 73:127044.

PMID: 35901669 PMC: 9297660. DOI: 10.1016/j.jtemb.2022.127044.


References
1.
Moore J, Doms R . The entry of entry inhibitors: a fusion of science and medicine. Proc Natl Acad Sci U S A. 2003; 100(19):10598-602. PMC: 196849. DOI: 10.1073/pnas.1932511100. View

2.
Mercer J, Schelhaas M, Helenius A . Virus entry by endocytosis. Annu Rev Biochem. 2010; 79:803-33. DOI: 10.1146/annurev-biochem-060208-104626. View

3.
Chanel-Vos C, Kielian M . Second-site revertants of a Semliki Forest virus fusion-block mutation reveal the dynamics of a class II membrane fusion protein. J Virol. 2006; 80(12):6115-22. PMC: 1472568. DOI: 10.1128/JVI.00167-06. View

4.
Lee K, Pessi A, Gui L, Santoprete A, Talekar A, Moscona A . Capturing a fusion intermediate of influenza hemagglutinin with a cholesterol-conjugated peptide, a new antiviral strategy for influenza virus. J Biol Chem. 2011; 286(49):42141-42149. PMC: 3234914. DOI: 10.1074/jbc.M111.254243. View

5.
Zheng Y, Martin C, Qin Z, Kielian M . The domain I-domain III linker plays an important role in the fusogenic conformational change of the alphavirus membrane fusion protein. J Virol. 2011; 85(13):6334-42. PMC: 3126531. DOI: 10.1128/JVI.00596-11. View